Title for MeetingAbstracts
Alphabetical listing of titles
Antibody Responses to Hepatitis A Virus Vaccine (HAVV) among HIV-Infected Children with Evidence of Immunologic Reconstitution.
Antibody Responses to Hepatitis A Virus Vaccine among HIV-infected Children with Evidence of Immunologic Reconstitution.
Antibody responses to influenza vaccines in HIV infected patients.
Antibody responses to neutralizing domains of gp120 in HIV(-) vaccinees boosted with homologous or heterologous rgp120. The NIAID AIDS Vaccine Evaluation Group.
Antibody responses to pneumococcal polysaccharides (PnPS) in HIV-infected children immunized with pneumococcal vaccine (PV).
Antibody responses to recombinant 38kDa protein of Mycobacterium tuberculosis in HIV-infected and non HIV-infected tuberculosis patients.
Antibody responses to RSV infection in HIV infected children.
Antibody responses to selected peptides of HIV-1 gp160 in immunized or HIV-1 infected individuals.
Antibody titers prior to HAART predict treatment outcome.
Antibody to hepatitis C virus (HCV) in blood donors positive for HIV.
Antibody to herpes simplex virus type 2 as a marker of sexual risk behaviour in rural Tanzania.
Antibody to HIV-1 in intravenous drug users (IVDU) entering methadone treatment programs (MTP) in Boston.
Antibody to HTLV I/II among blood donors in four cities of the United States.
Antibody to human endogenous retrovirus peptide (HERV 4.1) in urine of HIV-1 positive patients.
Antibody to ICAM-1 Blocks Sexual Transmission of Cell-associated HIV-1.
Antibody to LFA-1 Blocks HIV-1 Infection in Primary Cells through the Activation of Caspase 8.
Antibody to LFA-1 blocks infection of HIV in T cells and monocytes.
Antibody to pneumococcal polysaccharide vaccine in children with HIV infection: effect of revaccination.
Antibody to the CD4 binding site of gp120 (CD4BS Ab): prevalence, temporal development, correlation with virus load and prognostic value.
Antibody to the human IFN alpha receptor reduces the loss of CD4 + T cells in macaques infected with the simian immunodeficiency virus (SIV).
Antibody to V3 loop peptide does not predict vertical transmission of HIV.
Antibody-binding epitopes of HIV-1 envelope glycoproteins.
Antibody-dependent cellular cytotoxicity (ADCC) correlates with plasma HIV RNA level and CD4+ cell count.
Antibody-dependent cellular cytotoxicity (ADCC) in HIV infection.
Antibody-dependent cellular cytotoxicity (ADCC) in HIV-1 infected patients receiving a recombinant gp160 envelope vaccine: contributions of host factors and vaccine.
Antibody-dependent cellular cytotoxicity mediated by HTLV-I and HTLV-II positive human sera, as well as sera from rabbits immunized with HTLV-I and HTLV-II peptides.
Antibody-dependent, complement-mediated enhancement of HIV infection (C'-ADE) in a human, EBV-transformed B-cell line.
Antibody-mediated enhancement of HIV infectivity: mechanisms and significance.
Antibody-mediated neutralization against dual tropic viruses depends on coreceptor usages.
Antibody-Mediated Neutralization of Subtype C HIV-1.